Delivery Order SPE2DR25D3017-SPE2DR26F3EK5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,417.68 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-tablet units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,430.62 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit doses), with a completion date of December 2, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,339.92 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $23,628.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for RINVOQ ER 15 MG tablets (30-count units) valued at $55,438.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting open and competitive procurement. The contract is set to be completed by November 10, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,978.47 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for RINVOQ ER 15 mg tablets (quantity: 30 units), with completion targeted for November 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $197,052.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of September 18, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $26,154.99 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of RINVOQ ER 30 mg tablets (quantity: 30-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,409.40 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $11,779.01 on November 18, 2025, for RINVOQ ER 15 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 19, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EK5Delivery Order
The Defense Logistics Agency awarded a $23,204.03 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit doses). This is a non-set-aside, competitively awarded contract with performance to be completed by December 9, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly supplies brand-name and generic medications, vaccines, and medical devices to federal healthcare systems through competitive awards with the Defense Logistics Agency. The company's extensive portfolio of federal medical procurements demonstrates its capability to deliver critical pharmaceutical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This RINVOQ ER order exemplifies the routine pharmaceutical deliveries executed through AmerisourceBergen's prime vendor relationship with DLA, supporting the medical supply chain for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 12/7/25 |